MARKET

LEXX

LEXX

Lexaria Bioscience Corp
NASDAQ
1.080
+0.020
+1.89%
After Hours: 1.030 -0.05 -4.63% 17:33 05/09 EDT
OPEN
1.050
PREV CLOSE
1.060
HIGH
1.100
LOW
1.040
VOLUME
94.59K
TURNOVER
--
52 WEEK HIGH
4.440
52 WEEK LOW
1.010
MARKET CAP
21.04M
P/E (TTM)
-1.8468
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LEXX last week (0428-0502)?
Weekly Report · 5d ago
Lexaria Bioscience Secures $2 Million in Direct Stock Offering
TipRanks · 04/28 20:37
Weekly Report: what happened at LEXX last week (0421-0425)?
Weekly Report · 04/28 12:01
Lexaria Bioscience Secures $2 Million in Direct Stock Offering
TipRanks · 04/25 20:38
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss
Benzinga · 04/25 17:03
Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results
Benzinga · 04/25 14:10
Lexaria Bioscience announces $2M registered direct offering; shares slip 19%
Seeking Alpha · 04/25 13:19
Lexaria Bioscience prices 2M shares at $1.00 in registered direct offering
TipRanks · 04/25 12:15
More
About LEXX
More
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery formulation and processing platform technology improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. The Company’s segment includes Intellectual Property, B2B Production, and Research and Development. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its focus is the investigation and the incorporation of its DehydraTECH drug delivery technology with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to enhance absorption and reduce adverse side effects. The Company operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 48 patents granted and many patents pending worldwide.
Recently
Symbol
Price
%Change

Webull offers Lexaria Bioscience Corp stock information, including NASDAQ: LEXX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LEXX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LEXX stock methods without spending real money on the virtual paper trading platform.